Mitsubishi Tanabe Pharma Cited In New Regulatory Violation Of Blood Unit
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharma subsidiary Benesis, maker of blood products, was ordered by the Health Ministry to improve its compliance with regulations involving the way it ships its products.